Search company, investor...
Search
Ikena Oncology company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

ikenaoncology.com

Founded Year

2016

Stage

IPO | IPO

Total Raised

$249M

Date of IPO

3/26/2021

Market Cap

0.13B

Stock Price

3.88

About Ikena Oncology

Ikena Oncology (NASDAQ: IKNA) discovers and develops patient-directed therapies for cancer patients who need life-saving treatment.

Ikena Oncology Headquarters Location

645 Summer Street Suite 101

Boston, Massachusetts, 02210,

United States

857-273-8343

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ikena Oncology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ikena Oncology is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Ikena Oncology Patents

Ikena Oncology has filed 10 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Clusters of differentiation
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/8/2020

6/14/2022

Transcription factors, Clusters of differentiation, Immunology, Cytokines, Immune system

Grant

Application Date

4/8/2020

Grant Date

6/14/2022

Title

Related Topics

Transcription factors, Clusters of differentiation, Immunology, Cytokines, Immune system

Status

Grant

Latest Ikena Oncology News

Ikena Oncology : Corporate Presentation - Fall 2022

Sep 28, 2022

(marketscreener.com) Corporate Presentation Fall 2022 Developing Biology-Driven Medicines and Expanding the Impact of Targeted Oncology Ikena Mission ...https://www.marketscreener.com/quote/stock/IKENA-ONCOLOGY-INC-120405762/news/Ikena-Oncology-Corporate-Presentation-Fall-2022-41881297/?utm_medium=RSS&utm_content=20220928

Ikena Oncology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ikena Oncology Rank

  • When was Ikena Oncology founded?

    Ikena Oncology was founded in 2016.

  • Where is Ikena Oncology's headquarters?

    Ikena Oncology's headquarters is located at 645 Summer Street, Boston.

  • What is Ikena Oncology's latest funding round?

    Ikena Oncology's latest funding round is IPO.

  • How much did Ikena Oncology raise?

    Ikena Oncology raised a total of $249M.

  • Who are the investors of Ikena Oncology?

    Investors of Ikena Oncology include OrbiMed Advisors, Atlas Venture, Surveyor Capital, Fidelity Investments, HealthCor Management and 10 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.